A government-commissioned study had been meant to inform new dietary guidelines, and found risks associated with even light drinking.

Even what many Americans consider moderate drinking is linked to an increased risk of death, disability, and chronic diseases such as cancer and heart disease, according to a new study in the Journal of Studies on Alcohol and Drugs,

Even what many Americans consider moderate drinking is linked to an increased risk of death, disability, and chronic diseases such as cancer and heart disease, according to a new study published in the Journal of Studies on Alcohol and Drugs.

Add Yahoo as a preferred source to see more of our stories on Google. Researchers believe the so-called "wonder drugs" semaglutide and liraglutide could have other uses than fighting obesity, such as curbing addiction to alcohol. Patrick Pleul/dpa ...

FRESNO, Calif. (KFSN) -- April marks both Stress Awareness Month and Alcohol Awareness Month, prompting local health professionals and service organizations to spotlight the effects of alcohol abuse and the resources available to support people seeking help.

Sara Moniuszko is a health and lifestyle reporter at CBSNews.com. Previously, she wrote for USA Today, where she was selected to help launch the newspaper's wellness vertical. She now covers breaking and trending news for CBS News' HealthWatch. In the ...

Follow this section to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this tag to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in ...

A study conducted on male Wistar rats found that administering phytocannabinoids once daily reduced voluntary alcohol consumption. They tested three different compounds—cannabinol, tetrahydrocannabivarin,

Share on Pinterest A growing body of evidence suggests that GLP-1 drugs prescribed for obesity and diabetes could also help treat addiction. FreshSplash/Getty Images GLP-1 drugs like Ozempic and Mounjaro are emerging as a potential treatment for alcohol ...

Recent studies continue to support a decades-old drug as an alternative means of reducing alcohol consumption. The prescription opioid antagonist, called naltrexone, was first approved by the FDA to treat opioid dependence in 1984. A decade later, it was ...